series-a
Stage
1
Investors
About
Beeline Medicines is a clinical-stage biotechnology company developing precision medicines that target immune dysfunction drivers to treat autoimmune and inflammatory diseases such as lupus.
Explore Beeline Medicines's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.